Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

Item
http://www.wikidata.org/entity/Q38900093
Production and clinical development of nanoparticles for gene deliveryAttacking the supply wagons to starve cancer cells to death.Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.Nanomaterials in Targeting Cancer Stem Cells for Cancer TherapyTargeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells.Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity.Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?
P2860

Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

Item
http://www.wikidata.org/entity/Q38900093
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
@en
type
label
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
@en
prefLabel
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P921
P356
P1433
P1476
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
@en
P2093
P304
P31
P356
10.1016/J.BIOMATERIALS.2015.01.068
P478
P50
P577
P698
P921